Information Contained in this Report On September 28, 2023, Inventiva S.A. entered into a Sales Agreement with Cowen and Company, LLC with respect to an equity offering.
Item 1.01. Entry Into a Material Definitive Agreement.
On June 16, 2023, Iovance Biotherapeutics, Inc. entered into a
new Open Market Sale Agreement with Jefferies LLC with respect to an at the. | June 16, 2023
Item 1.02 Termination of a Material Definitive Agreement.
As previously disclosed, on March 22, 2021, Syndax Pharmaceuticals, Inc. entered into a sales agreement with
Cowen and Company, LLC ,. | May 26, 2023
You should read the following discussion and analysis of our financial condition
and results of operations together with our Unaudited Condensed Consolidated
Financial Statements and related notes. | May 4, 2023